| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/09/2004 | WO2004098581A3 Oral spray to reduce cold symptoms and duration of same |
| 12/09/2004 | WO2004098577A3 Dosage form containing (s)-pantoprazole as active ingredient |
| 12/09/2004 | WO2004093942A9 Temperature responsive systems |
| 12/09/2004 | WO2004089339A3 Lipid particles having asymmetric lipid coating and method of preparing same |
| 12/09/2004 | WO2004087102A3 A process for preparing a pharmaceutical active ingredient with high specific surface area |
| 12/09/2004 | WO2004085712A3 Multi-functional polymeric materials and their uses |
| 12/09/2004 | WO2004084900A8 Topical formulation and use of buspirone |
| 12/09/2004 | WO2004084863A8 Method of producing small microspheres of sugar, microspheres thus obtained and applications thereof |
| 12/09/2004 | WO2004082564A3 Coated enzyme granules |
| 12/09/2004 | WO2004080446B1 Treatment of intestinal conditions with n-2,3,3-tetramethylbicyclo[2.2.1]heptan-2-amine |
| 12/09/2004 | WO2004078108A3 Fibrate tablet and method for the production thereof |
| 12/09/2004 | WO2004073765A8 Drug delivery device and syringe for filling the same |
| 12/09/2004 | WO2004066925B1 Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same |
| 12/09/2004 | WO2004062628A3 Gilsonite derived pharmaceutical delivery compositions and methods |
| 12/09/2004 | WO2004032863A3 Oral formulations for proteins and polypeptides |
| 12/09/2004 | WO2004024168A8 Composition and method for use in intestinal cleansing procedures |
| 12/09/2004 | WO2004014336A3 Opioid-receptor antagonists in transdermal systems having buprenorphine |
| 12/09/2004 | WO2003105800A3 Film-shaped mucoadhesive administration form for administering cannabis active ingredients |
| 12/09/2004 | WO2003101486A3 Thermosensitive polymer carriers having a modifiable physical structure for biochemical analysis, diagnosis, and therapy |
| 12/09/2004 | WO2003101422A3 Pharmaceutical preparations for oral administration, containing ion-exchange resins loaded with active ingredients and intrinsically viscous gelling agents as thickening agents |
| 12/09/2004 | WO2003061630A8 Tabletting process |
| 12/09/2004 | US20040249365 Implantable osmotic pump |
| 12/09/2004 | US20040249364 Device and method for dispensing medication to tissue lining a body cavity |
| 12/09/2004 | US20040249363 Implantable, refillable infusion device and septum replacement kit |
| 12/09/2004 | US20040249133 Use of lipopeptides or lipoproteins for treating lung infections and lung tumours |
| 12/09/2004 | US20040249035 Granulate or powder for producing coating or binding agents for medicaments |
| 12/09/2004 | US20040248993 for skin care, comprising 1,5-pentanediol and a carrier, free of polysiloxane, volatile siloxane, phosphatidylcholine, creatine, carnitine, panthenol, pyruvic acid, lauric acid monoglyceride, or myristic acid monoglyceride; treating dry skin or dermatitis; patches and containers; optionally with drugs |
| 12/09/2004 | US20040248974 Self emulsifying drug delivery system |
| 12/09/2004 | US20040248966 A drug contains melatonin, other melatonergic agents, melatonin agonists and melatonin antagonists, in an effective amount within the range of 0.0025 to 50 mg, and other therapeutic agent; improving the restorative quality of sleep; sustained release |
| 12/09/2004 | US20040248962 Ketorolac tromethamine compositions for treating or preventing ocular pain |
| 12/09/2004 | US20040248942 Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid |
| 12/09/2004 | US20040248939 Stable pharmaceutical compositions comprising acid labile benzimidazoles |
| 12/09/2004 | US20040248924 Compositions for treatment of common cold |
| 12/09/2004 | US20040248914 Method for the treatment of overactive bladder |
| 12/09/2004 | US20040248901 Microemulsified with fatty acid or alcohol and surfactant; bioavailability; low cost, capsules |
| 12/09/2004 | US20040248891 Imidazotriazinone-containing compositions for nasal administration |
| 12/09/2004 | US20040248874 Anti-microbial composition comprising a metal ion chelating agent |
| 12/09/2004 | US20040248870 High-purity composition comprising (7alpha, 17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one and a process for purifying (7alpha, 17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one |
| 12/09/2004 | US20040248867 Novel anti-inflammatory 17.alpha.-heterocyclic-esters of 17.beta.carbothioate androstane derivatives |
| 12/09/2004 | US20040248847 Neutralized with dextran; adjustment of ph; prevent eye damage |
| 12/09/2004 | US20040248846 Intranasal administration of triptans |
| 12/09/2004 | US20040248845 Hyaluronic acid in soft gel form |
| 12/09/2004 | US20040248843 Process for the preparation of tablets comprising s-adenosylmethionine |
| 12/09/2004 | US20040248835 Administering by inhalation, injection or orally; Rna interference in vitro; genetic engineering |
| 12/09/2004 | US20040248833 Therapeutic delivery compositions and methods of use thereof |
| 12/09/2004 | US20040248832 Enhancement of transfection of dna into the liver |
| 12/09/2004 | US20040248831 Oligodeoxynucleic acid modified with (thio)phosphate |
| 12/09/2004 | US20040248804 Nasal administration of the LH-RH analog Leuprolide |
| 12/09/2004 | US20040248799 Compositions and methods for treating cancer and hyperproliferative disorders |
| 12/09/2004 | US20040248797 Pharmaceutical compositions of erythropoietin |
| 12/09/2004 | US20040248778 Stable galenic freeze-dried pharmaceutical preparation of recombined carbohydrate-binding polypeptides |
| 12/09/2004 | US20040248771 Pharmaco-dietary preparation having a nutrition-supplementing and nutrition-enhancing effect |
| 12/09/2004 | US20040248769 hydrolytic; inhibits arginyl endopeptidase or serine protease activity; air cleaner; fabric treatment |
| 12/09/2004 | US20040248326 Hydrogel compositions, devices, and microscale components |
| 12/09/2004 | US20040248320 Medical device with array of electrode-containing reservoirs |
| 12/09/2004 | US20040248266 Method for production of archidonic acid |
| 12/09/2004 | US20040247895 System for releasing active substances and active agents |
| 12/09/2004 | US20040247870 Method of preparing sustained release microparticles |
| 12/09/2004 | US20040247776 Method and device for coating pharmaceutical products |
| 12/09/2004 | US20040247746 Delivery units of thick orally soluble polymer |
| 12/09/2004 | US20040247744 Vitamin-containing orally soluble films |
| 12/09/2004 | US20040247716 Composition containing asiasari radix extracts for protecting brain cells and improving memory |
| 12/09/2004 | US20040247706 Transdermal dietary supplement comprising parthenolide |
| 12/09/2004 | US20040247705 Transdermal compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms |
| 12/09/2004 | US20040247693 Modifying the fatty acid composition of cell membranes of organs and tissues |
| 12/09/2004 | US20040247692 Poviding an aspherical lens having an aspherical surface and an opposite flat surface; defining a multiple-step grating in the flat surface. |
| 12/09/2004 | US20040247691 wound healing and tissue forming compositions with suitable cells affixed to prosthetic devices; microbeads are prepared by coagulation and emulsification of fibrinogen, thrombin and factor XIII without gluteraldehyde as a crosslinking agent |
| 12/09/2004 | US20040247689 Low temperature storage, high pressure micronization of nifedipine, leuprolide, or salmeterol, having low bioavailability or extended release formulations |
| 12/09/2004 | US20040247688 Method and apparatus for preparing microparticles using in-line solvent extraction |
| 12/09/2004 | US20040247687 Suspending an active ingredient in a cationic copolymer dispersion, salt-formation and pelletization by dropping the dispersion into an aqueous anionic polymer solution, separating and drying the pellets; time-release drug delivery for vaginal use, implants, films, transdermal systems, or cosmetics |
| 12/09/2004 | US20040247684 Thermostable aqueous solution or gel or lyophilized powders for an implantable drug delivery device; improved heat and oxidation resistance |
| 12/09/2004 | US20040247683 Aminoglucosides, such as streptomycin; oral dosage form; tuberculosis |
| 12/09/2004 | US20040247681 An acrylated polypropylene glycol or 1,2-propylene oxide adduct copolymerized with an acrylic silyl ester or an acrylic ketone; controlled release ocular inserts; glaucoma, cataracts |
| 12/09/2004 | US20040247680 Targeted delivery of controlled release polymer systems |
| 12/09/2004 | US20040247679 Formulation of an active agent such as antibiotic, a water soluble or water swellable polymer, and an acid in given amounts; zero order release profile; extended release oral dosage forms |
| 12/09/2004 | US20040247677 Each layer contains a soluble agent, disintigrant and swelling agent; rapidly dissolves in the mouth when contatcted with saliva, forming an easy to swallow suspension |
| 12/09/2004 | US20040247676 The active and barrier layers each contain two or more hydrophilic polymers, a lipophilic substance, and an adjuvant; side effect reduction; single daily dosage |
| 12/09/2004 | US20040247675 Easy to swallow oral medicament composition |
| 12/09/2004 | US20040247674 Drug delivery system |
| 12/09/2004 | US20040247673 Wet granulated particle form; compression; milling; benign prostate hyperplasia ; anticholesterol agents; antilipemic agents; Alzheimer's disease |
| 12/09/2004 | US20040247672 Injectable sustained release compositions |
| 12/09/2004 | US20040247671 Solid drug formulation and device for storage and controlled delivery thereof |
| 12/09/2004 | US20040247670 A homo- or copolymer of (N-(2-hydroxypropyl) methacrylamide mono- or dilactate) having a lower critical solution temperature (LCST) that changes during incubation in an aqueous solution; controlled and targeted release micelles and hydrogels |
| 12/09/2004 | US20040247669 Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth |
| 12/09/2004 | US20040247668 Controlled release composite |
| 12/09/2004 | US20040247667 Novel compound |
| 12/09/2004 | US20040247666 Prompt-release formulations containing an active ingredient solubilised, suspended or embedded in an amphiphilic matrix; improved pharmacokinetics |
| 12/09/2004 | US20040247665 A sryinge-like device extrudes a pill enclosed in a lubricating food carrier to mask the medicinal scent and aid humans or animals in swallowing |
| 12/09/2004 | US20040247664 forming an oil phase mixture of perfumes, essential oils, viatmins, antioxidants, proteins, lipids, cosmetics, dyes, pigments, brighteners, antisoilants, antifoam agents, antiagglomerants, or discoloration inhibitors and a block polymer; aqueous microemulsification; gelation; improved storage stability |
| 12/09/2004 | US20040247663 Liposomes with effector biomolecules attached to the distal ends of hydrophilic polymer chains provide increased time in the bloodstream; polymyxin B used for septic shock |
| 12/09/2004 | US20040247662 Systemic immune activation method using nucleic acid-lipid complexes |
| 12/09/2004 | US20040247661 injectable liposomal composition for delivery of large amounts of water-soluble substance comprises a plurality of liposomal vesicles having a high weight ratio of lipid to encapsulated water-soluble substance which is distributed over the liposomal vesicles; high efficiency of encapsulation |
| 12/09/2004 | US20040247660 Protein-stabilized liposomal formulations of pharmaceutical agents |
| 12/09/2004 | US20040247659 (Ester)-lysolecithins in liposomes |
| 12/09/2004 | US20040247658 Delivery system with increased bioavailability |
| 12/09/2004 | US20040247657 Plaster for the treatment of dysfunctions and disorders of nails, comprising sertaconazole |
| 12/09/2004 | US20040247656 Pressure sensitive adhesive matrix based on solvent-containing polyacrylates, a polyisobutylene, or an isoprene-styrene block copolymer improves the active ingredient storage stability; side effect reduction; Parkinson's Disease |
| 12/09/2004 | US20040247654 A radiation curable mixture of a swellable adhesive polymer that forms a pressure sensitive adhesive, a swelling agent, and herbal medicines; transdermal drug delivery |
| 12/09/2004 | US20040247652 covalently bonding a chitosan onto the textile by hydrolyzing the polyester followed by a single step amidation of the hydrolyzed polyester using a water-soluble carbodiimide with no intermediate N-hydroxysuccinimide ester; ambient temperature curing preserves fabric color |
| 12/09/2004 | US20040247649 Base medium formed from polymer, delivery unit being orally soluble such that it disintegrates relatively slowly when placed on the roof of a human mouth and licked, containing flavoring and dosage of desired delivery substance |